New shot could stop painful swelling attacks in kids with rare disease
NCT ID NCT05819775
First seen Jan 29, 2026 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tested a monthly injection called Garadacimab to prevent swelling attacks in children aged 2 to 11 with hereditary angioedema (HAE). The goal was to see if the drug is safe and reduces how often attacks happen. 22 children took part, and researchers tracked side effects and attack rates. This is a disease-control approach, not a cure, as ongoing treatment is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AARA Research Center
Dallas, Texas, 75231, United States
-
Barzilai University Medical Center
Ashkelon, 7830604, Israel
-
Bernstein Clinical Research
Cincinnati, Ohio, 45236, United States
-
Campbelltown Hospital, Western Sydney University
Campbelltown, NSW 2560, Australia
-
Charité - Universitätsmedizin Berlin
Berlin, 12203, Germany
-
Donald S. Levy M.D.
Orange, California, 92868, United States
-
HZRM Hämophilie Zentrum Rhein Main GmbH
Frankfurt am Main, Hesse, 60596, Germany
-
Medical Research of Arizona
Scottsdale, Arizona, 85251, United States
-
Ottawa Allergy Research Corp
Ottawa, K1H1E4, Canada
-
PennState Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Raffi Tachdjian MD, Inc.
Santa Monica, California, 90404, United States
-
Research Solutions of Arizona
Litchfield Park, Arizona, 85340, United States
-
Universitätsklinikum Frankfurt
Frankfurt am Main, 60590, Germany
Conditions
Explore the condition pages connected to this study.